Proceedings of the 1989 IEEE Particle Accelerator Conference, . 'Accelerator Science and Technology
DOI: 10.1109/pac.1989.73244
|View full text |Cite
|
Sign up to set email alerts
|

Advances of the feasibility study of the European Light Ion Medical Accelerator

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 1 publication
0
5
0
Order By: Relevance
“…There are no commercial cyclotron designs for carbon ion therapy available up to now. The company IBA is currently developing a u 400 MeV machine called C-400 (Jongen et al 2010) comparable to what was proposed in the EULIMA project (Mandrillon et al 1987). For 3 He ions, compact and cost-effective cyclotron designs may be feasible due to the relatively low final velocity (relativistic effects that complicate the acceleration in cyclotrons are still moderate at u 260 MeV ) and the less rigid beams would allow lighter magnets in the cyclotron, beam transport lines and gantry with a lower energy consumption.…”
Section: Accelerator Design Aspectsmentioning
confidence: 99%
“…There are no commercial cyclotron designs for carbon ion therapy available up to now. The company IBA is currently developing a u 400 MeV machine called C-400 (Jongen et al 2010) comparable to what was proposed in the EULIMA project (Mandrillon et al 1987). For 3 He ions, compact and cost-effective cyclotron designs may be feasible due to the relatively low final velocity (relativistic effects that complicate the acceleration in cyclotrons are still moderate at u 260 MeV ) and the less rigid beams would allow lighter magnets in the cyclotron, beam transport lines and gantry with a lower energy consumption.…”
Section: Accelerator Design Aspectsmentioning
confidence: 99%
“…In addition, the radiobiological properties of carbon ions were compared to heavier ions. Finally, socioeconomic studies on possible patient recruitments in the different countries were performed to demonstrate the necessity of a few therapy units all over Europe [22] .…”
Section: The Transition Phase 1980–1997mentioning
confidence: 99%
“…Synchrotrons are instead flexible machines, energy can be rapidly changed, different ion species can be accelerated, and they are a well-established technology. For these reasons, the EULIMA feasibility study recommended using synchrotrons for heavyion therapy [60], and indeed all European ion beam centers are currently using synchrotrons. IBA, the leading company in cyclotrons for proton therapy, is still working on the idea of the superconducting cyclotron for carbon ions (C400) [61], in collaboration with GANIL at Caen (France), but the project is still ongoing.…”
Section: Eulimamentioning
confidence: 99%